nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—PTGS2—bone cancer	0.431	1	CbGaD
Tetrahydrobiopterin—NOS3—Doxorubicin—bone cancer	0.391	0.844	CbGbCtD
Tetrahydrobiopterin—PTGS2—Cisplatin—bone cancer	0.0723	0.156	CbGbCtD
Tetrahydrobiopterin—TH—cranial nerve—bone cancer	0.00763	0.221	CbGeAlD
Tetrahydrobiopterin—NOS3—hindlimb—bone cancer	0.00578	0.167	CbGeAlD
Tetrahydrobiopterin—NOS3—appendage—bone cancer	0.00496	0.143	CbGeAlD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—FEV—bone cancer	0.00454	0.0769	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—FEV—bone cancer	0.00332	0.0562	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—DHFR—bone cancer	0.00328	0.0556	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—FEV—bone cancer	0.00261	0.0442	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—periosteum—bone cancer	0.00257	0.0745	CbGeAlD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—TNFRSF11A—bone cancer	0.00239	0.0404	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Tryptophan metabolism—CYP3A4—bone cancer	0.00239	0.0404	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism of nitric oxide—DHFR—bone cancer	0.00227	0.0385	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—leg—bone cancer	0.00205	0.0594	CbGeAlD
Tetrahydrobiopterin—PTGS2—hindlimb—bone cancer	0.00183	0.053	CbGeAlD
Tetrahydrobiopterin—PTGS2—cartilage tissue—bone cancer	0.0018	0.0522	CbGeAlD
Tetrahydrobiopterin—TH—connective tissue—bone cancer	0.00157	0.0455	CbGeAlD
Tetrahydrobiopterin—PTGS2—appendage—bone cancer	0.00157	0.0455	CbGeAlD
Tetrahydrobiopterin—NOS3—connective tissue—bone cancer	0.00142	0.041	CbGeAlD
Tetrahydrobiopterin—TH—Circadian rythm related genes—TNFRSF11A—bone cancer	0.00137	0.0232	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—GNA11—bone cancer	0.00115	0.0194	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—PAR1-mediated thrombin signaling events—GNA11—bone cancer	0.00111	0.0187	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Tryptophan metabolism—MDM2—bone cancer	0.0011	0.0186	CbGpPWpGaD
Tetrahydrobiopterin—TH—spinal cord—bone cancer	0.00104	0.0302	CbGeAlD
Tetrahydrobiopterin—NOS3—tendon—bone cancer	0.000973	0.0282	CbGeAlD
Tetrahydrobiopterin—NOS3—Thromboxane A2 receptor signaling—GNA11—bone cancer	0.000895	0.0152	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—IGF1R—bone cancer	0.000838	0.0142	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—GNA11—bone cancer	0.000809	0.0137	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—EZH2—bone cancer	0.000805	0.0136	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAU—bone cancer	0.000741	0.0126	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—PLAU—bone cancer	0.000736	0.0125	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—RGS1—bone cancer	0.000709	0.012	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—CDK4—bone cancer	0.000696	0.0118	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—PLAU—bone cancer	0.000642	0.0109	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—IGF1R—bone cancer	0.000635	0.0107	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiogenesis—MMP9—bone cancer	0.000621	0.0105	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—RB1—bone cancer	0.000605	0.0102	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—GNA11—bone cancer	0.000602	0.0102	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—bone cancer	0.000585	0.0099	CbGpPWpGaD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—MMP2—bone cancer	0.000581	0.00983	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—bone cancer	0.000562	0.00951	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—MMP2—bone cancer	0.000538	0.00912	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—NDUFA12—bone cancer	0.000498	0.00843	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—bone cancer	0.000496	0.00839	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—GNA11—bone cancer	0.000465	0.00786	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—EZH2—bone cancer	0.000462	0.00783	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—MMP2—bone cancer	0.000459	0.00778	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—CDK4—bone cancer	0.000455	0.0077	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—JUN—bone cancer	0.000452	0.00764	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—connective tissue—bone cancer	0.000449	0.013	CbGeAlD
Tetrahydrobiopterin—TH—ATF-2 transcription factor network—JUN—bone cancer	0.000449	0.00759	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—bone cancer	0.000439	0.00744	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—NT5C3A—bone cancer	0.000413	0.00698	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Plasma membrane estrogen receptor signaling—MMP9—bone cancer	0.000405	0.00685	CbGpPWpGaD
Tetrahydrobiopterin—Rhinorrhoea—Cisplatin—bone cancer	0.000395	0.0339	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—JUN—bone cancer	0.000391	0.00662	CbGpPWpGaD
Tetrahydrobiopterin—Infection—Carboplatin—bone cancer	0.000387	0.0332	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—BRAF—bone cancer	0.000381	0.00645	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—MMP9—bone cancer	0.000381	0.00644	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—ATF1—bone cancer	0.000368	0.00624	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—MMP2—bone cancer	0.000368	0.00623	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—NDUFA12—bone cancer	0.000364	0.00616	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—bone cancer	0.000363	0.00615	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.000361	0.00611	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—JUN—bone cancer	0.000359	0.00607	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—ATF1—bone cancer	0.000356	0.00602	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—tendon—bone cancer	0.000308	0.00892	CbGeAlD
Tetrahydrobiopterin—Body temperature increased—Carboplatin—bone cancer	0.000308	0.0264	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—NT5C3A—bone cancer	0.000302	0.00511	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—BRAF—bone cancer	0.000299	0.00507	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—bone marrow—bone cancer	0.000299	0.00864	CbGeAlD
Tetrahydrobiopterin—PTGS2—spinal cord—bone cancer	0.000298	0.00861	CbGeAlD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—JUN—bone cancer	0.000293	0.00496	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—NDUFA12—bone cancer	0.000286	0.00484	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—JUN—bone cancer	0.000284	0.00481	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—MMP9—bone cancer	0.000277	0.00468	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000275	0.00466	CbGpPWpGaD
Tetrahydrobiopterin—Polyuria—Cisplatin—bone cancer	0.000265	0.0227	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—JUN—bone cancer	0.000262	0.00444	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—CDK4—bone cancer	0.000261	0.00442	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—TP53—bone cancer	0.000258	0.00437	CbGpPWpGaD
Tetrahydrobiopterin—Nasal congestion—Cisplatin—bone cancer	0.000255	0.0219	CcSEcCtD
Tetrahydrobiopterin—NOS3—Thromboxane A2 receptor signaling—EGFR—bone cancer	0.000255	0.00431	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—EGFR—bone cancer	0.000248	0.00419	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—NT5C3A—bone cancer	0.000237	0.00401	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Cisplatin—bone cancer	0.000232	0.02	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—bone cancer	0.000225	0.00381	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—bone cancer	0.000224	0.0038	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—EGFR—bone cancer	0.000223	0.00378	CbGpPWpGaD
Tetrahydrobiopterin—Irritability—Cisplatin—bone cancer	0.000222	0.019	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000209	0.00354	CbGpPWpGaD
Tetrahydrobiopterin—Nasopharyngitis—Cisplatin—bone cancer	0.000208	0.0178	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—JUN—bone cancer	0.000206	0.00349	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—NDUFA12—bone cancer	0.000198	0.00336	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—TP53—bone cancer	0.000193	0.00327	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	0.000193	0.00327	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—BRAF—bone cancer	0.00019	0.00322	CbGpPWpGaD
Tetrahydrobiopterin—Cardiovascular disorder—Epirubicin—bone cancer	0.000187	0.0161	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—ENO2—bone cancer	0.000181	0.00306	CbGpPWpGaD
Tetrahydrobiopterin—Respiratory failure—Methotrexate—bone cancer	0.000179	0.0154	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Cisplatin—bone cancer	0.000177	0.0152	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000176	0.00299	CbGpPWpGaD
Tetrahydrobiopterin—Myocardial infarction—Cisplatin—bone cancer	0.000176	0.0151	CcSEcCtD
Tetrahydrobiopterin—Cardiovascular disorder—Doxorubicin—bone cancer	0.000173	0.0149	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—JUN—bone cancer	0.000168	0.00285	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—SPARC—bone cancer	0.000168	0.00285	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—DHFR—bone cancer	0.000168	0.00284	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—NT5C3A—bone cancer	0.000164	0.00278	CbGpPWpGaD
Tetrahydrobiopterin—Urine output increased—Methotrexate—bone cancer	0.000159	0.0136	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—ENO2—bone cancer	0.000158	0.00267	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—GNA11—bone cancer	0.000157	0.00265	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—GNA11—bone cancer	0.000154	0.0026	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00015	0.00254	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—DHFR—bone cancer	0.000146	0.00248	CbGpPWpGaD
Tetrahydrobiopterin—Polyuria—Methotrexate—bone cancer	0.000145	0.0125	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—bone cancer	0.000145	0.00246	CbGpPWpGaD
Tetrahydrobiopterin—Mediastinal disorder—Cisplatin—bone cancer	0.000145	0.0124	CcSEcCtD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—JUN—bone cancer	0.000144	0.00243	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—CYP3A4—bone cancer	0.000142	0.0024	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—KIT—bone cancer	0.00014	0.00237	CbGpPWpGaD
Tetrahydrobiopterin—Malnutrition—Cisplatin—bone cancer	0.00014	0.012	CcSEcCtD
Tetrahydrobiopterin—NOS3—Hemostasis—IL3—bone cancer	0.000139	0.00236	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—JUN—bone cancer	0.000139	0.00235	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000137	0.00231	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—ENO2—bone cancer	0.000132	0.00224	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	0.000127	0.00216	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000124	0.00211	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000123	0.00208	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—DHFR—bone cancer	0.000123	0.00207	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000122	0.00207	CbGpPWpGaD
Tetrahydrobiopterin—Irritability—Methotrexate—bone cancer	0.000122	0.0104	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—GSTP1—bone cancer	0.000121	0.00206	CbGpPWpGaD
Tetrahydrobiopterin—Convulsion—Cisplatin—bone cancer	0.000121	0.0104	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.000119	0.0102	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000118	0.0102	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—GNA11—bone cancer	0.000115	0.00194	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Cisplatin—bone cancer	0.000114	0.00981	CcSEcCtD
Tetrahydrobiopterin—Infection—Cisplatin—bone cancer	0.000113	0.00974	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CDK4—bone cancer	0.000113	0.00192	CbGpPWpGaD
Tetrahydrobiopterin—Nervous system disorder—Cisplatin—bone cancer	0.000112	0.00962	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—TP53—bone cancer	0.000111	0.00188	CbGpPWpGaD
Tetrahydrobiopterin—Skin disorder—Cisplatin—bone cancer	0.000111	0.00952	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.00011	0.00948	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Epirubicin—bone cancer	0.000109	0.00936	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—EGFR—bone cancer	0.000109	0.00184	CbGpPWpGaD
Tetrahydrobiopterin—Nasopharyngitis—Epirubicin—bone cancer	0.000107	0.00916	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—TGFBR2—bone cancer	0.000106	0.0018	CbGpPWpGaD
Tetrahydrobiopterin—Gastritis—Epirubicin—bone cancer	0.000106	0.00907	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000104	0.00893	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000104	0.00176	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—CYP3A4—bone cancer	0.000104	0.00176	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ENO2—bone cancer	0.000104	0.00176	CbGpPWpGaD
Tetrahydrobiopterin—Neutropenia—Methotrexate—bone cancer	0.000103	0.00885	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Methotrexate—bone cancer	0.000102	0.00879	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Doxorubicin—bone cancer	0.000101	0.00866	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Doxorubicin—bone cancer	9.87e-05	0.00848	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Cisplatin—bone cancer	9.86e-05	0.00847	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—RB1—bone cancer	9.85e-05	0.00167	CbGpPWpGaD
Tetrahydrobiopterin—Infestation NOS—Methotrexate—bone cancer	9.83e-05	0.00844	CcSEcCtD
Tetrahydrobiopterin—Infestation—Methotrexate—bone cancer	9.83e-05	0.00844	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Doxorubicin—bone cancer	9.77e-05	0.00839	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Epirubicin—bone cancer	9.65e-05	0.00828	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—DHFR—bone cancer	9.63e-05	0.00163	CbGpPWpGaD
Tetrahydrobiopterin—Upper respiratory tract infection—Epirubicin—bone cancer	9.59e-05	0.00823	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RGS1—bone cancer	9.33e-05	0.00158	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GRM4—bone cancer	9.33e-05	0.00158	CbGpPWpGaD
Tetrahydrobiopterin—Infestation—Epirubicin—bone cancer	9.2e-05	0.0079	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Epirubicin—bone cancer	9.2e-05	0.0079	CcSEcCtD
Tetrahydrobiopterin—NOS3—Hemostasis—PLAU—bone cancer	9.15e-05	0.00155	CbGpPWpGaD
Tetrahydrobiopterin—Body temperature increased—Cisplatin—bone cancer	9.03e-05	0.00775	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—GNA11—bone cancer	9e-05	0.00152	CbGpPWpGaD
Tetrahydrobiopterin—Urinary tract infection—Epirubicin—bone cancer	8.94e-05	0.00767	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Doxorubicin—bone cancer	8.92e-05	0.00766	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—GSTP1—bone cancer	8.88e-05	0.0015	CbGpPWpGaD
Tetrahydrobiopterin—Upper respiratory tract infection—Doxorubicin—bone cancer	8.87e-05	0.00761	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Methotrexate—bone cancer	8.76e-05	0.00752	CcSEcCtD
Tetrahydrobiopterin—NOS3—Disease—ENO2—bone cancer	8.59e-05	0.00145	CbGpPWpGaD
Tetrahydrobiopterin—Infestation—Doxorubicin—bone cancer	8.51e-05	0.00731	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Doxorubicin—bone cancer	8.51e-05	0.00731	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Cisplatin—bone cancer	8.42e-05	0.00722	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Doxorubicin—bone cancer	8.27e-05	0.0071	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Epirubicin—bone cancer	8.19e-05	0.00703	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—CYP3A4—bone cancer	8.16e-05	0.00138	CbGpPWpGaD
Tetrahydrobiopterin—Oedema peripheral—Epirubicin—bone cancer	8.13e-05	0.00698	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Metabolism—NDUFA12—bone cancer	8.11e-05	0.00137	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GRM1—bone cancer	8.09e-05	0.00137	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—DHFR—bone cancer	7.97e-05	0.00135	CbGpPWpGaD
Tetrahydrobiopterin—Mediastinal disorder—Methotrexate—bone cancer	7.95e-05	0.00683	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Cisplatin—bone cancer	7.82e-05	0.00671	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	7.71e-05	0.00131	CbGpPWpGaD
Tetrahydrobiopterin—Malnutrition—Methotrexate—bone cancer	7.68e-05	0.00659	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Doxorubicin—bone cancer	7.58e-05	0.00651	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Doxorubicin—bone cancer	7.53e-05	0.00646	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Epirubicin—bone cancer	7.44e-05	0.00639	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Cisplatin—bone cancer	7.26e-05	0.00623	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—KIT—bone cancer	7.24e-05	0.00123	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Cisplatin—bone cancer	7.2e-05	0.00618	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Cisplatin—bone cancer	7.2e-05	0.00618	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—ENO2—bone cancer	7.19e-05	0.00122	CbGpPWpGaD
Tetrahydrobiopterin—Malnutrition—Epirubicin—bone cancer	7.19e-05	0.00617	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—MMP9—bone cancer	7.1e-05	0.0012	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—GSTP1—bone cancer	6.98e-05	0.00118	CbGpPWpGaD
Tetrahydrobiopterin—Mediastinal disorder—Doxorubicin—bone cancer	6.88e-05	0.00591	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—BRAF—bone cancer	6.8e-05	0.00115	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Cisplatin—bone cancer	6.78e-05	0.00582	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Metabolism—NT5C3A—bone cancer	6.72e-05	0.00114	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Methotrexate—bone cancer	6.7e-05	0.00575	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—DHFR—bone cancer	6.67e-05	0.00113	CbGpPWpGaD
Tetrahydrobiopterin—Convulsion—Methotrexate—bone cancer	6.65e-05	0.00571	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Doxorubicin—bone cancer	6.65e-05	0.00571	CcSEcCtD
Tetrahydrobiopterin—Agitation—Epirubicin—bone cancer	6.6e-05	0.00567	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Methotrexate—bone cancer	6.54e-05	0.00561	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	6.49e-05	0.00557	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—PTGS2—bone cancer	6.29e-05	0.00107	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Epirubicin—bone cancer	6.27e-05	0.00538	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Methotrexate—bone cancer	6.27e-05	0.00538	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—GNA11—bone cancer	6.24e-05	0.00106	CbGpPWpGaD
Tetrahydrobiopterin—Convulsion—Epirubicin—bone cancer	6.23e-05	0.00535	CcSEcCtD
Tetrahydrobiopterin—Infection—Methotrexate—bone cancer	6.23e-05	0.00535	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Methotrexate—bone cancer	6.15e-05	0.00528	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Epirubicin—bone cancer	6.12e-05	0.00525	CcSEcCtD
Tetrahydrobiopterin—Agitation—Doxorubicin—bone cancer	6.11e-05	0.00525	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Methotrexate—bone cancer	6.09e-05	0.00523	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	6.08e-05	0.00522	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Epirubicin—bone cancer	5.87e-05	0.00504	CcSEcCtD
Tetrahydrobiopterin—Infection—Epirubicin—bone cancer	5.83e-05	0.005	CcSEcCtD
Tetrahydrobiopterin—Cough—Doxorubicin—bone cancer	5.8e-05	0.00498	CcSEcCtD
Tetrahydrobiopterin—NOS3—Disease—TGFBR2—bone cancer	5.77e-05	0.000978	CbGpPWpGaD
Tetrahydrobiopterin—Convulsion—Doxorubicin—bone cancer	5.76e-05	0.00495	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Epirubicin—bone cancer	5.75e-05	0.00494	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—EGFR—bone cancer	5.74e-05	0.000972	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	5.72e-05	0.000968	CbGpPWpGaD
Tetrahydrobiopterin—Musculoskeletal discomfort—Methotrexate—bone cancer	5.71e-05	0.0049	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SMO—bone cancer	5.7e-05	0.000965	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MDM2—bone cancer	5.7e-05	0.000965	CbGpPWpGaD
Tetrahydrobiopterin—Skin disorder—Epirubicin—bone cancer	5.7e-05	0.00489	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Doxorubicin—bone cancer	5.66e-05	0.00486	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—CYP3A4—bone cancer	5.65e-05	0.000957	CbGpPWpGaD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	5.62e-05	0.00483	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Methotrexate—bone cancer	5.52e-05	0.00474	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—PTGS2—bone cancer	5.49e-05	0.00093	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Doxorubicin—bone cancer	5.43e-05	0.00466	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Methotrexate—bone cancer	5.41e-05	0.00465	CcSEcCtD
Tetrahydrobiopterin—Infection—Doxorubicin—bone cancer	5.39e-05	0.00463	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Epirubicin—bone cancer	5.34e-05	0.00459	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Doxorubicin—bone cancer	5.32e-05	0.00457	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Doxorubicin—bone cancer	5.27e-05	0.00453	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GNA11—bone cancer	5.22e-05	0.000883	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Epirubicin—bone cancer	5.16e-05	0.00443	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Methotrexate—bone cancer	5.13e-05	0.0044	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Epirubicin—bone cancer	5.06e-05	0.00435	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	4.97e-05	0.000841	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Methotrexate—bone cancer	4.95e-05	0.00425	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Methotrexate—bone cancer	4.95e-05	0.00425	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Doxorubicin—bone cancer	4.94e-05	0.00424	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ATF1—bone cancer	4.85e-05	0.000821	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GSTP1—bone cancer	4.84e-05	0.000819	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TP53—bone cancer	4.82e-05	0.000816	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Epirubicin—bone cancer	4.8e-05	0.00412	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Doxorubicin—bone cancer	4.78e-05	0.0041	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL3—bone cancer	4.73e-05	0.0008	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Doxorubicin—bone cancer	4.69e-05	0.00402	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Epirubicin—bone cancer	4.64e-05	0.00398	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Epirubicin—bone cancer	4.64e-05	0.00398	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Methotrexate—bone cancer	4.62e-05	0.00396	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—PTGS2—bone cancer	4.6e-05	0.000779	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Doxorubicin—bone cancer	4.44e-05	0.00381	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Epirubicin—bone cancer	4.32e-05	0.00371	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Doxorubicin—bone cancer	4.29e-05	0.00368	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Doxorubicin—bone cancer	4.29e-05	0.00368	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Methotrexate—bone cancer	4.29e-05	0.00368	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Methotrexate—bone cancer	4.14e-05	0.00356	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TGFBR2—bone cancer	4.04e-05	0.000685	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Epirubicin—bone cancer	4.01e-05	0.00345	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Doxorubicin—bone cancer	4e-05	0.00343	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Methotrexate—bone cancer	3.99e-05	0.00342	CcSEcCtD
Tetrahydrobiopterin—Rash—Methotrexate—bone cancer	3.95e-05	0.00339	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Methotrexate—bone cancer	3.95e-05	0.00339	CcSEcCtD
Tetrahydrobiopterin—NOS3—Disease—KIT—bone cancer	3.94e-05	0.000667	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Methotrexate—bone cancer	3.93e-05	0.00337	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.91e-05	0.000661	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—EGFR—bone cancer	3.89e-05	0.000659	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Epirubicin—bone cancer	3.88e-05	0.00333	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF1R—bone cancer	3.8e-05	0.000644	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Epirubicin—bone cancer	3.73e-05	0.0032	CcSEcCtD
Tetrahydrobiopterin—Nausea—Methotrexate—bone cancer	3.72e-05	0.0032	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Doxorubicin—bone cancer	3.71e-05	0.00319	CcSEcCtD
Tetrahydrobiopterin—NOS3—Disease—BRAF—bone cancer	3.7e-05	0.000627	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Epirubicin—bone cancer	3.7e-05	0.00317	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Epirubicin—bone cancer	3.7e-05	0.00317	CcSEcCtD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—bone cancer	3.68e-05	0.000623	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Epirubicin—bone cancer	3.67e-05	0.00315	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—PTGS2—bone cancer	3.61e-05	0.000612	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Doxorubicin—bone cancer	3.59e-05	0.00308	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Disease—ENO2—bone cancer	3.51e-05	0.000595	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Epirubicin—bone cancer	3.48e-05	0.00299	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Doxorubicin—bone cancer	3.45e-05	0.00296	CcSEcCtD
Tetrahydrobiopterin—Rash—Doxorubicin—bone cancer	3.42e-05	0.00294	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Doxorubicin—bone cancer	3.42e-05	0.00293	CcSEcCtD
Tetrahydrobiopterin—Headache—Doxorubicin—bone cancer	3.4e-05	0.00292	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.28e-05	0.000555	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—DHFR—bone cancer	3.26e-05	0.000552	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Doxorubicin—bone cancer	3.22e-05	0.00277	CcSEcCtD
Tetrahydrobiopterin—NOS3—Disease—MDM2—bone cancer	3.1e-05	0.000525	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTGS2—bone cancer	2.99e-05	0.000506	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ENO2—bone cancer	2.94e-05	0.000498	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KIT—bone cancer	2.76e-05	0.000467	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—DHFR—bone cancer	2.73e-05	0.000462	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—BRAF—bone cancer	2.59e-05	0.000439	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GNA11—bone cancer	2.55e-05	0.000432	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS2—bone cancer	2.51e-05	0.000424	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TGFBR2—bone cancer	2.36e-05	0.0004	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP3A4—bone cancer	2.31e-05	0.000391	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MDM2—bone cancer	2.17e-05	0.000368	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EGFR—bone cancer	2.12e-05	0.000359	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTP1—bone cancer	1.98e-05	0.000335	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—JUN—bone cancer	1.89e-05	0.00032	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MMP9—bone cancer	1.84e-05	0.000311	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KIT—bone cancer	1.61e-05	0.000273	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—BRAF—bone cancer	1.51e-05	0.000256	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EGFR—bone cancer	1.49e-05	0.000251	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MDM2—bone cancer	1.27e-05	0.000215	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—bone cancer	1.25e-05	0.000211	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EGFR—bone cancer	8.67e-06	0.000147	CbGpPWpGaD
